As robotic techniques continue to evolve, these surgical procedures hold great potential for further transforming cancer treatment and enhancing the quality of care for patients ...
Stephen Trowbridge; Chief Financial Officer, Executive Vice President; AngioDynamics Inc Good morning and welcome to the AngioDynamics fiscal year 2025 second quarter earnings call at this time.